303318109	303318109	CD	B-NP	O
|	|	NN	I-NP	O
TMH	TMH	NN	I-NP	O
|	|	NN	I-NP	O
31830318	31830318	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9376273	9376273	CD	B-NP	O
|	|	CC	I-NP	O
10/22/2007	10/22/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Upper	Upper	NNP	I-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/10/2007	11/10/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/22/2007	10/22/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
KNIERIM	KNIERIM	NNP	B-NP	O
,	,	,	O	O
JERRELL	JERRELL	NNP	B-NP	O
H	H	NNP	I-NP	O
475-07-01-2	475-07-01-2	NN	I-NP	O
Ge	Ge	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
4/18/07	4/18/07	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TOOLSIRAM	TOOLSIRAM	NNP	B-NP	O
,	,	,	O	O
MELVIN	MELVIN	NNP	B-NP	O
MERLIN	MERLIN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CHILDREN	CHILDREN	NNP	I-NP	O
'S	'S	POS	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
HFA	HFA	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NNP	I-NP	O
INH	INH	NNP	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Wheezing	Wheezing	NNP	I-NP	O
,	,	,	O	O
Other	Other	NNP	B-NP	O
:	:	:	O	O
cough	cough	IN	B-PP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/11/07	7/11/07	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ALBUTEROL	ALBUTEROL	NN	B-NP	B-protein
INHALER	INHALER	NN	I-NP	I-protein
HFA	HFA	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
QID	QID	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
241736632	241736632	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
EPINEPHRINE	EPINEPHRINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
has	have	VBZ	B-VP	O
tolerated	tolerate	VBN	I-VP	O
previously	previously	RB	B-ADVP	O
Previous	Previous	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/11/07	7/11/07	CD	B-NP	O
by	by	IN	B-PP	O
FISHMAN	FISHMAN	NNP	B-NP	O
,	,	,	O	O
RUSSELL	RUSSELL	NNP	B-NP	O
T	T	NNP	I-NP	O
,	,	,	O	O
MD	MD	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ALBUTEROL	ALBUTEROL	NN	B-NP	O
INHALER	INHALER	NN	I-NP	O
HFA	HFA	NN	I-NP	O
INH	INH	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
142590417	142590417	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
EPINEPHRINE	EPINEPHRINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
takes	take	NNS	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
Number	Number	NN	I-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
100	100	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
WELLBUTRIN	WELLBUTRIN	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BUPROPION	BUPROPION	NN	I-NP	O
HCL	HCL	NN	I-NP	O
SUSTAINED	SUSTAINED	VBD	B-VP	O
RELEAS	RELEAS	NN	B-NP	O
...	...	:	O	O
-RRB-	-RRB-	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
LASIX	LASIX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
August	August	NNP	I-NP	O
GLIPIZIDE	GLIPIZIDE	NNP	I-NP	O
XL	XL	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
ROBITUSSIN	ROBITUSSIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GUAIFENESIN	GUAIFENESIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
cough	cough	NN	B-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
sugar	sugar	NN	B-NP	O
free	free	JJ	I-NP	O
formulation	formulation	NN	I-NP	O
KCL	KCL	NN	I-NP	O
SLOW	SLOW	NN	I-NP	O
RELEASE	RELEASE	NN	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
TBH	TBH	NN	B-NP	O
Potassium	Potassium	NN	I-NP	O
Chloride	Chloride	NN	I-NP	O
Policy	Policy	NN	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/11/07	7/11/07	CD	B-NP	O
by	by	IN	B-PP	O
SIRKOCH	SIRKOCH	NNP	B-NP	O
,	,	,	O	O
MICHAEL	MICHAEL	NNP	B-NP	O
S	S	NNP	I-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIOVAN	DIOVAN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
80	80	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
520998717	520998717	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/11/07	7/11/07	CD	B-NP	O
by	by	IN	B-PP	O
COUNIHAN	COUNIHAN	NNP	B-NP	O
,	,	,	O	O
MILES	MILES	NNP	B-NP	O
H	H	NNP	I-NP	O
,	,	,	O	O
MD	MD	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIOVAN	DIOVAN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
992521774	992521774	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
-	-	HYPH	I-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
MILK	MILK	NN	I-NP	O
OF	OF	IN	B-PP	O
MAGNESIA	MAGNESIA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MAGNESIUM	MAGNESIUM	NNP	I-NP	O
HYDROXIDE	HYDROXIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MILLILITERS	MILLILITERS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
PROTONIX	PROTONIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
ZOCOR	ZOCOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

DIOVAN	DIOVAN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/11/07	7/11/07	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/11/07	7/11/07	CD	B-NP	O
by	by	IN	B-PP	O
VOTTA	VOTTA	NNP	B-NP	B-protein
,	,	,	O	O
ROSCOE	ROSCOE	NNP	B-NP	O
M	M	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
-	-	HYPH	I-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
Number	Number	NN	I-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Please	Please	NNP	B-NP	O
see	see	VB	B-VP	O
your	your	PRP$	B-NP	O
Primary	Primary	NNP	I-NP	O
Card	Card	NNP	I-NP	O
Doctor	Doctor	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
1-2	1-2	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
PROCAINE	PROCAINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
,	,	,	O	O
EPINEPHRINE	EPINEPHRINE	NN	B-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
,	,	,	O	O
Shellfish	Shellfish	NN	B-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
Contrast	Contrast	NN	I-NP	O
,	,	,	O	O
DIAZEPAM	DIAZEPAM	NN	B-NP	O
,	,	,	O	O
ACE	ACE	NN	B-NP	O
Inhibitor	Inhibitor	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Chest	Chest	NNP	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Upper	Upper	NNP	I-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
diabetes	diabetes	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
asthma	asthma	NN	I-NP	O
CHF	CHF	NN	I-NP	O
irritable	irritable	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
anxiety	anxiety	NN	I-NP	O
lumbar	lumbar	NN	I-NP	O
disc	disc	NN	I-NP	O
disease	disease	NN	I-NP	O
angina	angina	NN	I-NP	O
/	/	SYM	B-VP	O
?	?	.	O	O

cad	cad	NN	B-NP	O
diverticulosis	diverticulosis	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ECHO	ECHO	NNP	I-NP	O
5/18/07	5/18/07	CD	I-NP	O
:	:	:	O	O
Nl	Nl	NN	B-NP	B-protein
EF	EF	NN	I-NP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

no	no	DT	B-NP	O
wma.no	wma.no	NN	I-NP	O
evidence	evidence	NN	I-NP	O
chamber	chamber	NN	I-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

CARDIAC	CARDIAC	NN	B-NP	O
PET	PET	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
rest/stress	rest/stress	NN	I-NP	O
w	w	NN	I-NP	O
persantine	persantine	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
Image	Image	NN	B-NP	O
quality	quality	NN	I-NP	O
was	be	VBD	B-VP	O
excellent	excellent	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
images	image	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
normal	normal	JJ	B-NP	O
LV	LV	NN	I-NP	O
size	size	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
also	also	RB	B-ADVP	O
demonstrated	demonstrate	VBD	B-VP	O
normal	normal	JJ	B-NP	O
RV	RV	NN	I-NP	O
size	size	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
RV	RV	NN	I-NP	O
tracer	tracer	NN	I-NP	O
uptake	uptake	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
perfusion	perfusion	NN	I-NP	O
defects	defect	NNS	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
stress	stress	NN	I-NP	O
or	or	CC	I-NP	O
rest	rest	NN	I-NP	O
images	image	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
Gated	Gate	VBN	B-NP	O
PET	PET	NN	I-NP	O
:	:	:	O	O
Rest	R	JJS	B-NP	O
LV	LV	NN	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
53	53	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
ESVI	ESVI	NN	I-NP	B-protein
29	29	CD	I-NP	I-protein
ml/m	ml/m	NN	I-NP	I-protein
^	^	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
post-stress	post-stress	JJ	I-NP	O
LV	LV	NN	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
was	be	VBD	B-VP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
ESVI	ESVI	NNP	B-NP	B-protein
23	23	CD	I-NP	I-protein
ml/m	ml/m	NN	I-NP	I-protein
^	^	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
LV	LV	NN	I-NP	O
volumes	volume	NNS	I-NP	O
appeared	appear	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

Demonstrated	Demonstrate	VBN	B-NP	O
normal	normal	JJ	I-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
thickening	thickening	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
RV	RV	NN	I-NP	O
function	function	NN	I-NP	O
appeared	appear	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
RFA	RFA	NN	B-NP	B-protein
:	:	:	O	O
ROMI	ROMI	NN	B-NP	O
.	.	.	O	O

CC	CC	NN	B-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
tightness	tightness	NN	I-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
.	.	.	O	O

HPI	HPI	LS	B-LST	B-cell_type
:	:	:	O	O
62F	62F	NN	B-NP	O
hx	hx	NN	I-NP	O
dCHF	dCHF	NN	I-NP	O
,	,	,	O	O
CABG	CABG	NN	B-NP	O
'04	'04	CD	I-NP	O
p/w	p/w	NN	I-NP	O
cough	cough	NN	I-NP	O
x	x	SYM	B-VP	O
2	2	CD	B-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
hx	hx	NN	B-NP	O
asthma	asthma	NN	I-NP	O
,	,	,	O	O
laryngitis	laryngitis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
wk	wk	NN	I-NP	O
hx	hx	NN	I-NP	O
inc	inc	NN	I-NP	O
SOB	SOB	NN	I-NP	O
,	,	,	O	O
weakness	weakness	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
2d	2d	NN	B-NP	O
hx	hx	NN	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
chest	chest	NN	B-NP	O
tightness/burning	tightness/burne	VBG	B-VP	O
.	.	.	O	O

Occasinal	Occasinal	JJ	B-NP	O
L	L	NN	I-NP	O
lateral	lateral	JJ	I-NP	O
chest	chest	NN	I-NP	O
twinges	twinge	NNS	I-NP	O
and	and	CC	O	O
anterior	anterior	JJ	B-NP	O
chest	chest	NN	I-NP	O
twinges	twinge	VBZ	B-VP	O
2/2	2/2	CD	B-NP	O
sternal	sternal	JJ	I-NP	O
wires	wire	NNS	I-NP	O
and	and	CC	O	O
recent	recent	JJ	B-NP	O
breast	breast	NN	I-NP	O
reduction	reduction	NN	I-NP	O
.	.	.	O	O

Prior	Prior	JJ	B-NP	O
anginal	anginal	JJ	I-NP	O
equivalent	equivalent	NN	I-NP	O
was	be	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
arm	arm	NN	I-NP	O
pain/tightness	pain/tightness	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
having	have	VBG	B-VP	O
inc	inc	NN	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
PND	PND	NN	I-NP	B-protein
or	or	CC	I-NP	O
LEE	LEE	NN	I-NP	B-protein
.	.	.	O	O

Sent	Sent	NN	B-NP	O
in	in	IN	B-PP	O
from	from	IN	B-PP	O
PCP	PCP	NN	B-NP	B-DNA
for	for	IN	B-PP	O
TWI	TWI	NN	B-NP	O
in	in	IN	B-PP	O
V1-V2	V1-V2	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
appeared	appear	VBN	I-VP	O
in	in	IN	B-PP	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
ECG	ECG	NN	I-NP	O
's	's	POS	B-NP	O
in	in	IN	B-PP	O
last	last	JJ	B-NP	B-protein
2	2	CD	I-NP	I-protein
yrs	yr	NNS	I-NP	I-protein
since	since	IN	B-PP	O
CABG	CABG	NN	B-NP	B-protein
.	.	.	O	O

hypertensive	hypertensive	JJ	B-ADJP	O
in	in	IN	B-PP	O
ED	ED	NNP	B-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
CP	CP	NN	B-NP	B-DNA
free	free	JJ	B-ADJP	O
,	,	,	O	O
given	give	VBN	B-PP	O
ASA	ASA	NNP	B-NP	O
.	.	.	O	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
10/4	10/4	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Scantlin	Scantlin	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
pLAD	pLAD	NN	I-NP	O
,	,	,	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
RCA	RCA	NN	I-NP	O
,	,	,	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
pOM1	pOM1	NN	I-NP	O
,	,	,	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
co-dom	co-dom	NN	I-NP	O
pLCx	pLCx	NN	I-NP	O
.	.	.	O	O

LIMA	LIMA	NN	B-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
SVG1	SVG1	NN	B-NP	B-protein
to	to	TO	B-PP	O
PDA	PDA	NN	B-NP	B-protein
,	,	,	O	O
SVG2	SVG2	NN	B-NP	B-protein
to	to	TO	B-PP	O
OM1	OM1	NN	B-NP	B-protein
,	,	,	O	O
SVG2	SVG2	NN	B-NP	B-protein
to	to	TO	B-PP	O
D1	D1	NN	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
HTN	HTN	NN	I-NP	B-protein
,	,	,	O	O
lipids	lipid	NNS	B-NP	O
.	.	.	O	O

nonsmoker	nonsmoker	JJ	B-ADJP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
ddCHF	ddCHF	NN	I-NP	O
on	on	IN	B-PP	O
diuretics	diuretic	NNS	B-NP	O
,	,	,	O	O
dry	dry	JJ	B-NP	O
weight	weight	NN	I-NP	O
195lb	195lb	NN	I-NP	O
.	.	.	O	O

followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
THO	THO	NN	B-NP	O
CHF	CHF	NN	I-NP	O
NP	NP	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
DM	DM	NN	I-NP	O
-	-	HYPH	I-NP	O
asthma	asthma	NN	I-NP	O
-	-	HYPH	B-NP	O
anemia	anemia	NN	I-NP	O
-	-	HYPH	O	O
post-partum	post-partum	JJ	B-NP	O
DVT/PE	DVT/PE	NN	I-NP	O
-	-	HYPH	B-NP	O
lactose	lactose	NN	I-NP	O
intol	intol	NN	I-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
diverticulosis	diverticulosis	NN	B-NP	O
,	,	,	O	O
IBS	IBS	NNP	B-NP	B-protein
,	,	,	O	O
lumbar	lumbar	NN	B-NP	O
disc	disc	NN	I-NP	O
disease	disease	NN	I-NP	O
-	-	HYPH	B-NP	O
recent	recent	JJ	I-NP	O
breast	breast	NN	I-NP	O
reduction	reduction	NN	I-NP	O
.	.	.	O	O
.	.	.	O	O

Home	Home	NN	B-NP	O
meds	med	NNS	I-NP	O
:	:	:	O	O
glucotrol	glucotrol	NN	B-NP	O
XL	XL	NN	I-NP	O
10	10	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	B-DNA
81	81	CD	I-NP	I-DNA
,	,	,	O	O
wellbutrin	wellbutrin	NN	B-NP	O
sa	sa	NN	I-NP	O
150	150	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
diovan	diovan	NN	B-NP	O
80	80	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
kdur	kdur	VBP	B-VP	O
20	20	CD	B-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	B-protein
inh	inh	NN	I-NP	I-protein
prn	prn	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
rarely	rarely	RB	B-ADVP	I-protein
-RRB-	-RRB-	NN	B-NP	I-protein
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
75	75	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
zocor	zocor	NN	B-NP	B-DNA
40	40	CD	I-NP	I-DNA
.	.	.	O	O
.	.	.	O	O

Allergies	Allergy	NNS	B-NP	O
:	:	:	O	O
iodine	iodine	NN	B-NP	O
,	,	,	O	O
lactose	lactose	NN	B-NP	O
,	,	,	O	O
valium	valium	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
novocaine/marcaine/bup	novocaine/marcaine/bup	NN	B-NP	O
ivacaine	ivacaine	NN	I-NP	O
,	,	,	O	O
.	.	.	O	O

Admit	Admit	NN	B-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
hypertensive	hypertensive	JJ	B-NP	O
HR	HR	NN	I-NP	O
75	75	CD	I-NP	O
A+O	A+O	NNP	I-NP	O
x3	x3	CD	I-NP	O
Cor	Cor	NNP	I-NP	O
reg	reg	NN	I-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
base	base	NN	B-NP	O
Chest	Chest	NNP	I-NP	O
bilat	bilat	NN	I-NP	O
CTA	CTA	NNP	I-NP	O
.	.	.	O	O

ttp	ttp	NN	B-NP	O
over	over	IN	B-PP	O
sternum	sternum	NN	B-NP	O
and	and	CC	I-NP	O
L	L	NN	I-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

abd	abd	NN	B-NP	O
benign	benign	JJ	I-NP	O
,	,	,	I-NP	O
ext	ext	JJ	I-NP	O
warm	warm	JJ	I-NP	O
w/o	w/o	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
:	:	:	O	O
admit	admit	VB	B-VP	O
to	to	TO	B-PP	O
floor	floor	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O
.	.	.	O	O

Studies	Study	NNS	B-NP	O
-	-	:	O	O
ECG	ECG	NN	B-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
75	75	CD	I-NP	I-protein
LAD/LAFB	LAD/LAFB	NN	I-NP	I-protein
.	.	.	O	O

poor	poor	JJ	B-NP	O
RWP	RWP	NN	I-NP	O
.	.	.	O	O

currently	currently	RB	B-ADVP	O
TWI	TWI	NN	B-NP	O
in	in	IN	B-PP	O
v1	v1	NN	B-NP	O
,	,	,	O	O
v2	v2	NN	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	B-protein
since	since	IN	B-PP	O
CABG	CABG	NN	B-NP	B-protein
,	,	,	O	O
TWI	TWI	NN	B-NP	O
in	in	IN	B-PP	O
V1	V1	NN	B-NP	O
and	and	CC	I-NP	O
V2	V2	NN	I-NP	B-protein
come	come	VB	B-VP	O
and	and	CC	I-VP	O
go	go	VB	I-VP	O
-RRB-	-RRB-	SYM	B-NP	B-protein
-	-	HYPH	B-NP	O
CXR	CXR	NN	I-NP	B-protein
:	:	:	O	O
neg	neg	NN	B-NP	O
.	.	.	O	O
.	.	.	O	O

Impression	Impression	NN	B-NP	O
:	:	:	O	O
62F	62F	NN	B-NP	O
CAD/CABG	CAD/CABG	NN	I-NP	O
,	,	,	O	O
dCHF	dCHF	NN	B-NP	O
admitted	admit	VBN	B-VP	O
after	after	IN	B-SBAR	O
presented	present	VBN	B-VP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	I-NP	O
worsening	worsening	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
cough	cough	NN	I-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
grade	grade	NN	I-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

Likely	Likely	JJ	B-NP	O
combo	combo	NN	I-NP	O
of	of	IN	B-PP	O
URI-triggered	URI-triggered	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
gastroenteritis	gastroenteritis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
?	?	.	O	O

CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

unlikely	unlikely	JJ	B-NP	O
UA	UA	NN	I-NP	O
.	.	.	O	O

Plan	Plan	NN	B-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
Chest	Chest	NNP	I-NP	O
pain	pain	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
I	I	PRP	B-NP	O
-RRB-	-RRB-	VBP	B-VP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
.	.	.	O	O

High	High	JJ	B-NP	O
risk	risk	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	O	O
inc	inc	NN	B-NP	O
SOB	SOB	NN	I-NP	O
.	.	.	O	O

Not	Not	RB	O	O
convincing	convince	VBG	B-VP	O
for	for	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
but	but	CC	O	O
having	have	VBG	B-VP	O
progressive	progressive	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
.	.	.	O	O

ECG	ECG	NN	B-NP	O
changes	change	NNS	I-NP	O
nonspecific	nonspecific	JJ	B-ADJP	O
,	,	,	O	O
not	not	RB	B-VP	O
concerning	concern	VBG	I-VP	O
as	as	RB	I-VP	O
noted	note	VBN	I-VP	O
on	on	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
prior	prior	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
ASA	ASA	NNP	I-NP	O
,	,	,	O	O
BB	BB	NNP	B-NP	O
,	,	,	O	O
ARB	ARB	NN	B-NP	B-protein
,	,	,	O	O
statin	statin	NN	B-NP	O
.	.	.	O	O

Noted	Note	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypertensive	hypertensive	JJ	B-ADJP	O
during	during	IN	B-PP	O
hospital	hospital	NN	B-NP	O
stay	stay	NN	I-NP	O
with	with	IN	B-PP	O
SBP	SBP	NN	B-NP	B-protein
's	's	POS	B-NP	O
in	in	IN	B-PP	O
130-160	130-160	CD	B-NP	O
.	.	.	O	O

HR	HR	NN	B-NP	O
60-80s	60-80	NNS	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
discharge	discharge	VB	I-VP	O
on	on	IN	B-PP	O
increased	increase	VBN	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
-LRB-	-LRB-	HYPH	O	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
instead	instead	RB	B-PP	O
of	of	IN	I-PP	O
75	75	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

-LRB-	-LRB-	NN	B-NP	B-protein
P	P	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
:	:	:	O	O
Repeat	Repeat	NN	B-NP	O
echo	echo	NN	I-NP	O
for	for	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
.	.	.	O	O

ddCHF	ddCHF	NN	B-NP	O
.	.	.	O	O

Preserved	Preserve	VBN	B-NP	O
EF	EF	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
or	or	CC	I-NP	O
changes	change	NNS	I-NP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
systolic/diastolic	systolic/diastolic	JJ	B-NP	O
function	function	NN	I-NP	O
or	or	CC	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

Discharge	Discharge	NN	B-NP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
lasix	lasix	NN	I-NP	O
with	with	IN	B-PP	O
standing	stand	VBG	B-VP	O
potassium	potassium	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	JJ	B-NP	B-protein
R	R	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
:	:	:	O	O
Sinus	Sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
events	event	NNS	I-NP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

T	T	NN	B-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
V1-V2	V1-V2	NN	B-NP	O
originally	originally	RB	B-VP	O
noted	note	VBN	I-VP	O
varied	vary	VBD	B-VP	O
from	from	IN	B-PP	O
flat	flat	JJ	B-ADJP	O
to	to	TO	B-PP	O
slightly	slightly	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
other	other	JJ	I-NP	O
dynamic	dynamic	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O
.	.	.	O	O

COUGH	COUGH	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
gives	give	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
cough	cough	NN	I-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
recently	recently	RB	I-VP	O
involved	involve	VBN	I-VP	O
sputum	sputum	NN	B-NP	O
production	production	NN	I-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
grade	grade	NN	I-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
are	be	VBP	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
viral	viral	JJ	I-NP	O
bronchitis	bronchitis	NN	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
reactive	reactive	JJ	I-NP	O
airway	airway	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
got	get	VBD	B-VP	O
relief	relief	NN	B-NP	O
from	from	IN	B-PP	O
duoneb	duoneb	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
albuterol	albuterol	NN	I-NP	O
inhaler	inhaler	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
empiric	empiric	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
protonix	protonix	NN	B-NP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
reflux	reflux	NN	B-NP	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
exacerbate	exacerbate	VB	I-VP	O
reactive	reactive	JJ	B-NP	O
airway	airway	NN	I-NP	O
disease	disease	NN	I-NP	O
or	or	CC	B-PP	O
in	in	IN	B-PP	O
itself	itself	PRP	B-NP	O
cause	cause	VBP	B-VP	O
night	night	NN	B-NP	O
time	time	NN	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
on	on	IN	B-PP	O
CXR	CXR	NN	B-NP	B-protein
.	.	.	O	O

-	-	HYPH	B-NP	O
Sputum	Sputum	NN	I-NP	O
gram	gram	NN	I-NP	O
stain	stain	NN	I-NP	O
and	and	CC	I-NP	O
culture	culture	NN	I-NP	O
pending	pende	VBG	B-PP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	O
were	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
concerning	concern	VBG	B-NP	O
changes	change	NNS	I-NP	O
on	on	IN	B-PP	O
your	your	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

Numerous	Numerous	JJ	B-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
and	and	CC	O	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
gets	get	VBZ	B-VP	O
adequate	adequate	JJ	B-NP	O
blood	blood	NN	I-NP	O
flow	flow	NN	I-NP	O
during	during	IN	B-PP	O
rest	rest	NN	B-NP	O
and	and	CC	I-NP	O
exercise	exercise	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
attack	attack	NN	I-NP	O
either	either	RB	B-ADVP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
cough	cough	NN	I-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
are	be	VBP	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
upper	upper	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
may	may	MD	B-VP	O
also	also	RB	I-VP	O
make	make	VB	I-VP	O
your	your	PRP$	B-NP	O
asthma	asthma	NN	I-NP	O
worse	worse	JJR	B-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
would	would	MD	B-VP	O
recommend	recommend	VB	I-VP	O
using	use	VBG	I-VP	O
your	your	PRP$	B-NP	O
asthma	asthma	NN	I-NP	O
inhaler	inhaler	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
cough	cough	NN	B-NP	O
and	and	CC	I-NP	O
wheeze	wheeze	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
we	we	PRP	B-NP	O
would	would	MD	B-VP	O
recommend	recommend	VB	I-VP	O
trying	try	VBG	I-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
stomach	stomach	NN	B-NP	O
acid	acid	NN	I-NP	O
reducer	reducer	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
protonix	protonix	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
as	as	IN	B-PP	O
acid	acid	NN	B-NP	O
reflux	reflux	NN	I-NP	O
can	can	MD	B-VP	O
also	also	RB	I-VP	O
make	make	VB	I-VP	O
cough	cough	NN	B-NP	O
worse	worse	JJR	B-ADJP	O
.	.	.	O	O
.	.	.	O	O

KEY	KEY	NNP	B-NP	O
MEDICATION	MEDICATION	NNP	I-NP	O
CHANGES	CHANGES	NNP	I-NP	O
:	:	:	O	O
Continue	Continue	VB	B-VP	O
all	all	DT	B-NP	O
medicines	medicine	NNS	I-NP	O
that	that	IN	B-NP	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
before	before	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
changes	change	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Atenolol	Atenolol	NN	B-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
increase	increase	NN	I-NP	O
from	from	IN	B-PP	O
75	75	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

You	You	PRP	B-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
high	high	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
even	even	RB	B-ADVP	O
on	on	IN	B-PP	O
your	your	PRP$	B-NP	O
current	current	JJ	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Prilosec	Prilosec	NNP	B-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
may	may	MD	B-VP	O
help	help	VB	I-VP	O
your	your	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Albuterol	Albuterol	NNP	B-NP	O
inhaler	inhaler	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Ventolin	Ventolin	NNP	I-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Please	Please	VB	B-VP	O
take	take	VB	I-VP	O
as	as	RB	I-VP	O
directed	direct	VBN	I-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Robitussion	Robitussion	NN	B-NP	O
,	,	,	I-NP	O
sugar	sugar	NN	I-NP	O
free	free	JJ	I-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
for	for	IN	B-PP	O
cough	cough	NN	B-NP	O
.	.	.	O	O
.	.	.	O	O

Please	Please	VB	B-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
in	in	RP	B-PRT	O
on	on	IN	B-PP	O
how	how	WRB	B-ADVP	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
doing	do	VBG	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
2	2	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Return	Return	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ER	ER	NN	I-NP	B-protein
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
having	have	VBG	I-VP	O
difficulty	difficulty	NN	B-NP	O
breathing	breathing	NN	I-NP	O
,	,	,	O	O
recurrent	recurrent	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
concerning	concern	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Followup	Followup	NN	B-NP	O
sputum	sputum	NN	I-NP	O
gram	gram	NN	I-NP	O
stain/culture	stain/culture	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
check	check	NN	I-NP	O
on	on	IN	B-PP	O
increased	increase	VBN	B-NP	O
dose	dose	NN	I-NP	O
atenolol	atenolol	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Cough	Cough	NNP	B-NP	O
:	:	:	O	O
improved	improve	VBN	B-VP	O
on	on	IN	B-PP	O
albuterol	albuterol	NN	B-NP	O
inhaler	inhaler	NN	I-NP	O
and	and	CC	O	O
proton-pump	proton-pump	JJ	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
?	?	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
MASKELL	MASKELL	NNP	B-NP	O
,	,	,	O	O
BOBBY	BOBBY	NNP	B-NP	O
C	C	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DQ060	DQ060	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4/18/07	4/18/07	CD	I-NP	O
@	@	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
28	28	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

